Proposed Clinical Specialist Inpatient/Outpatient Service Coverage (4FTE) EXPANDED SERVICES Specialist Hem/Onc Gen Gen Gen PICU CV1 Peds PCU ED 4cath1 4cath2 SDO Peds Peds Peds surg 1 2 3 A 12 mo 2 mo 6 mo B 2 mo 8 mo 4 mo 12 mo C 3 mo 3 mo 9 mo D* 12 mo 12 mo 12mo 12mo 12mo Faculty A 6 mo 8 mo Faculty B 4 mo 4 mo 4mo Faculty C 3 mo 3 mo 3 mo TOTAL 12 mo 12 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 12 mo 12 mo 12mo months of mo mo coverage * position being requested The charts above highlight the plans for the expanded coverage of services for this new position. Cost-Savings Projections Critically ill patients often have multiple organ dysfunctions, which results in altered drug pharmacokinetics and pharmacodynamics. According to one study, the presence of a pharmacist in an adult ICU has resulted in $1700 per patient decrease in total charges. Based on the results of the study, a clinical pharmacist in PCU would save Institution B approximately $155,000 annually on drug modifications due to end organ function. Another study of cost
Proposed Clinical Specialist Inpatient/Outpatient Service Coverage (4FTE) EXPANDED SERVICES Specialist Hem/Onc Gen Peds 1 Gen Peds 2 Gen Peds 3 PICU CV1 Peds surg PCU ED 4cath1 4cath2 SDO A 12 mo 2 mo 6 mo B 2 mo 8 mo 4 mo 12 mo C 3 mo 3 mo 9 mo D* 12 mo 12 mo 12mo 12mo 12mo Faculty A 6 mo 8 mo Faculty B 4 mo 4 mo 4mo Faculty C 3 mo 3 mo 3 mo TOTAL months of coverage 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12 mo 12mo * position being requested The charts above highlight the plans for the expanded coverage of services for this new position. Cost-Savings Projections Critically ill patients often have multiple organ dysfunctions, which results in altered drug pharmacokinetics and pharmacodynamics. According to one study, the presence of a pharmacist in an adult ICU has resulted in $1700 per patient decrease in total charges. Based on the results of the study, a clinical pharmacist in PCU would save Institution B approximately $155,000 annually on drug modifications due to end organ function. Another study of cost
Business_Case_-_Pediatric_Operational_FTE_Justification.docx